Xijia Medical has triumphantly concluded its angel round funding, securing tens of millions of yuan. The procured funds will be strategically allocated towards the marketing efforts and the further research and development of its AI brain connectomics products. Leveraging MRI data, the company pioneers in mapping personalized brain networks, offering indispensable support for neurosurgical procedures and the treatment of central nervous system disorders. Currently, Xijia Medical is engaged in collaborative clinical trials with numerous hospitals and has established neuromodulation clinics in Shenzhen and Shanghai to deliver its services. Moreover, the company is actively developing products tailored for scientific research support and consumer-grade brain health assessments.
